Skip to main content

Table 2 Post-ERCP diagnostics of patients in the study and control groups

From: Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial

 

Treatment group

(N = 4)

Control group

(N = 17)

P value

Choledocholithiasis

2

7

0.35

Benign biliary stenosis and/or leakage

1

4

 

Suspected sphincter of Oddi dysfunction

0

5

 

Normal cholangiogram and/or pancreatogram

1

1

 

Severity of the episodes of Pancreatitis

   

Mild

3

14

0.60

Moderate

1

3